These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26123374)

  • 21. Corticostriatal and Dopaminergic Response to Beer Flavor with Both fMRI and [(11) C]raclopride Positron Emission Tomography.
    Oberlin BG; Dzemidzic M; Harezlak J; Kudela MA; Tran SM; Soeurt CM; Yoder KK; Kareken DA
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1865-73. PubMed ID: 27459715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.
    Jaskiw GE; Kirkbride B; Newbould E; Young D; Durkalski V; Bongiovanni R
    Psychopharmacology (Berl); 2005 Jun; 179(4):713-24. PubMed ID: 15682305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized in vivo detection of dopamine release using 18F-fallypride PET.
    Ceccarini J; Vrieze E; Koole M; Muylle T; Bormans G; Claes S; Van Laere K
    J Nucl Med; 2012 Oct; 53(10):1565-72. PubMed ID: 22933820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.
    Alexander M; Rothman RB; Baumann MH; Endres CJ; Brasić JR; Wong DF
    Synapse; 2005 May; 56(2):94-9. PubMed ID: 15729739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
    Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder.
    Schrantee A; Mutsaerts H; Bouziane C; Tamminga H; Bottelier MA; Reneman L
    Neuroimage Clin; 2017; 13():123-129. PubMed ID: 27942455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.
    Zakiniaeiz Y; Hillmer AT; Matuskey D; Nabulsi N; Ropchan J; Mazure CM; Picciotto MR; Huang Y; McKee SA; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2019 Dec; 44(13):2205-2211. PubMed ID: 31269510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.
    Del Campo N; Chamberlain SR; Sahakian BJ; Robbins TW
    Biol Psychiatry; 2011 Jun; 69(12):e145-57. PubMed ID: 21550021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential increase of extracellular dopamine and serotonin in the 'prefrontal cortex' and striatum of pigeons during working memory.
    Karakuyu D; Herold C; Güntürkün O; Diekamp B
    Eur J Neurosci; 2007 Oct; 26(8):2293-302. PubMed ID: 17908172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.
    Sato S; Chiba T; Nishiyama S; Kakiuchi T; Tsukada H; Hatano T; Fukuda T; Yasoshima Y; Kai N; Kobayashi K; Mizuno Y; Tanaka K; Hattori N
    J Neurosci Res; 2006 Nov; 84(6):1350-7. PubMed ID: 16941649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study.
    Thobois S; Hassoun W; Ginovart N; Garcia-Larrea L; Le Cavorsin M; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Broussolle E; Leviel V
    Neurosci Lett; 2004 Sep; 368(1):46-51. PubMed ID: 15342132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.
    Hernaus D; Collip D; Kasanova Z; Winz O; Heinzel A; van Amelsvoort T; Shali SM; Booij J; Rong Y; Piel M; Pruessner J; Mottaghy FM; Myin-Germeys I
    Transl Psychiatry; 2015 Apr; 5(4):e547. PubMed ID: 25871972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine.
    Schiffer WK; Volkow ND; Fowler JS; Alexoff DL; Logan J; Dewey SL
    Synapse; 2006 Mar; 59(4):243-51. PubMed ID: 16385551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.